MYCN and neuroblastoma: In order to assess the effects of pharmacologic inhibition of PI3K on MYCN-driven cells, human Kelly MYCN-amplified neuroblastoma cells were treated with various PI3K inhibitors: PI-103, LY-294002, PIK-75, and PW-12.